Global X China Biotech Innovation ETF (CHB)
CHB is a passive ETF by Global X tracking the investment results of the Solactive China Biotech Innovation Index. CHB launched on Sep 22, 2020 and has a 0.67% expense ratio.
ETF Info
US37954Y2515
37954Y251
Sep 22, 2020
Global ex-U.S. (Broad)
1x
Solactive China Biotech Innovation Index
Multi-Cap
Blend
Expense Ratio
CHB has an expense ratio of 0.67%, placing it in the medium range.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Global X China Biotech Innovation ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
CHB
N/A
N/A
N/A
N/A
N/A
N/A
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of CHB, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -17.10% | -1.12% | -18.02% | ||||||||||
| 2023 | 10.26% | -5.92% | -7.16% | -0.17% | -9.71% | -5.65% | 3.52% | -7.49% | 2.79% | 6.22% | 5.23% | -4.12% | -13.60% |
| 2022 | -15.01% | 1.04% | -5.27% | -14.08% | -1.52% | 16.43% | -8.30% | -5.59% | -14.44% | -1.97% | 18.65% | -3.38% | -33.29% |
| 2021 | 6.22% | -1.70% | -5.00% | 15.61% | 1.57% | -1.47% | -6.70% | -6.41% | -1.85% | -3.29% | 1.33% | -10.27% | -13.52% |
| 2020 | 0.66% | 2.44% | -5.12% | 9.74% | 7.36% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Global X China Biotech Innovation ETF (CHB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
| Period | 2023 | 2022 |
|---|---|---|
| Dividend | $0.04 | $0.02 |
Dividend yield | 0.48% | 0.21% |
Monthly Dividends
The table displays the monthly dividend distributions for Global X China Biotech Innovation ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $6.72 | $6.72 | ||||||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 |
| 2022 | $0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.02 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Global X China Biotech Innovation ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Global X China Biotech Innovation ETF was 66.72%, occurring on Feb 5, 2024. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -66.72% | Feb 17, 2021 | 733 | Feb 5, 2024 | — | — | — |
| -10.8% | Oct 14, 2020 | 42 | Dec 11, 2020 | 15 | Jan 5, 2021 | 57 |
| -6.83% | Jan 26, 2021 | 4 | Jan 29, 2021 | 3 | Feb 3, 2021 | 7 |
| -1.74% | Jan 11, 2021 | 1 | Jan 11, 2021 | 1 | Jan 12, 2021 | 2 |
| -0.89% | Jan 13, 2021 | 1 | Jan 13, 2021 | 1 | Jan 14, 2021 | 2 |
Volatility
Volatility Chart
The current Global X China Biotech Innovation ETF volatility is 4.49%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.